Zhejiang's first hospital purchasing community announced the list of the first batch of drugs to be traded. Who do they all like?

Source: Medical magic cube data 2016-02-01 in order to encourage hospitals to negotiate with pharmaceutical companies, the general office of Zhejiang provincial government issued the opinions on reforming and improving the centralized purchasing mechanism of public hospitals on May 29, 2015, and proposed a new purchasing form of volume for price Medical and health institutions below the provincial level can form a purchasing community in the form of medical consortia and medical groups, while grass-roots medical and health institutions can form a purchasing community in the form of counties (cities, districts) On the basis of the bidding price, the purchasing community negotiates with drug manufacturers to make a final price confirmation The difference between the final confirmation price and the medical insurance payment standard or the reference sales price shall be turned over to the finance of the same level, and then the medical institution shall be rewarded according to the assessment At present, this kind of purchasing community has also begun to try out in Wenzhou and Ningbo The drug list of the first batch of price negotiation of Hangzhou procurement community includes 501 drug specifications, including 135 antihypertensive drugs, 103 cerebrovascular drugs, 91 coronary drugs, 76 hypoglycemic drugs, 56 asthma drugs and 40 lipid-lowering drugs Hangzhou released the list of proposed varieties of cerebrovascular diseases on December 28 last year, and the list of other five drugs on January 28 According to the analysis of the results of the two announcements, 67 varieties have been eliminated, the elimination rate is about 13%, and the final confirmed price has not been announced